After revenue boomed for biopharma manufacturers during the COVID pandemic, sales have stagnated for several CDMO giants, but Korean powerhouse Samsung Biologics has somehow avoided the slide. The company has reported another robust increase in its top line, with a
read moreAlready on its way to becoming a blockbuster drug, Johnson & Johnson’s Spravato has received another potential boost as the FDA has blessed the nasal spray to be used as a monotherapy for major depressive disorder. More: Johnson & Johnson's
read more
Preclinical data highlights potential in treating Alzheimer’s disease More: AlzeCure’s NeuroRestore ACD856 to be presented at AD/PD 2025 Source: News
read more
Combination therapy shows superior survival benefit over standard treatment More: EC approves lazertinib in combination with amivantamab for NSCLC patients Source: News
read moreLeo Pharma has stepped up to commercialize toripalimab in Europe, inking a deal with Shanghai Junshi Biosciences to secure the rights to promote and sell the PD-1 inhibitor in its home region. More: Leo bags EU rights to Junshi's Loqtorzi,
read moreAn observational study from Washington University in St. Louis has shed more light on the benefits—as well as the risks—of using new diabetes and weight loss drugs from Novo Nordisk and Eli Lilly. According to the study, researchers found that
read more© 1994 - 2026 B.M. Pharmaceuticals